Article
Iran Alleges Series Of 'False Flags' - Including On Kuwait Water Plant - Designed To Perpetuate War
Iran Alleges Series Of 'False Flags' - Including On Kuwait Water Plant - Designed To Perpetuate War
Via The Cradle
The Iranian military denied on Monday being behind the recent attack which hit a desalination plant in Kuwait, labeling the strike a US-Israeli false-flag operation aimed at "destabilizing and destroying the region."
"The brutal aggression by the Zionist regime against the desalination facility in Kuwait, carried out in recent hours under the pretext of accusing the Islamic Republic of Iran, is a sign of the vileness and depravity of the Zionist occupiers," the Khatam...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Apr 20, 2026 / Tyler Durden
Kuwait Declares Force Majeure As US Seizure Of Iranian Ship Escalates Tensions
Kuwait Declares Force Majeure As US Seizure Of Iranian Ship Escalates Tensions
By Charles Kennedy of OilPrice.com
Kuwait has declared force majeure on shipments of crude oil and refined products after disruptions at the Strait of Hormuz prevented some vessels from entering the Persian Gulf.
The move comes as tensions in the Strait escalated again following the U.S. seizure of an Iranian-flagged cargo vessel in the waterway.
According to Reuters, Kuwait Petroleum Corporation has notified customers that it is invoking contractual clauses allowing it to withhold certain scheduled deliveries after the blockade hindered...
Read more
Ludwig Von Mises
Selected Works of Ludwig Von Mises on Mises.org
Apr 24, 2026 / Tyler Durden
FDA Approves First Gene Therapy To Treat Deafness
FDA Approves First Gene Therapy To Treat Deafness
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
Federal regulators on Thursday approved the first gene therapy to restore hearing, just two months after the therapy’s maker formally requested a license.
Dr. Marty Makary, the Food and Drug Administration's commissioner, in an undated file photograph. Madalina Vasiliu/The Epoch Times
The Food and Drug Administration approved the Regeneron therapy, Otarmeni, for children and adults with severe or profound hearing loss associated with OTOF gene variants.
The approval came 61 days after Regeneron filed for a...
Read more




